Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3811 AL 3825

Meaning and purpose in Huntington's disease: a longitudinal study of its impact on quality of life

Sokol LL, Troost JP, Kluger BM, Applebaum AJ, Paulsen JS, Bega D, Frank S, Hauser JM, Boileau NR, Depp CA, Cella D, Carlozzi NE.

Ann Clin Transl Neurol. 2021 Aug;8(8):1668-1679. doi: 10.1002/acn3.51424. Epub 2021 Jul 20.

An unusual presentation of Huntington's disease

Schulze Westhoff M, Osmanovic A, Meissner C, Heck J, Mahmoudi N, Hendrich C, Berding G, Seifert J, Bleich S, Frieling H, Krüger T, Groh A.

Clin Case Rep. 2021 Jul 16;9(7):e04547. doi: 10.1002/ccr3.4547. eCollection 2021 Jul.

Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus

Paß T, Wiesner RJ, Pla-Martín D.

Front Mol Biosci. 2021 Jun 30;8:676187. doi: 10.3389/fmolb.2021.676187. eCollection 2021.

Primary Mitochondrial Disorders Overview

Chinnery PF.

2000 Jun 8 [updated 2021 Jul 29]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Neurodegenerative movement disorders: An epigenetics perspective and promise for the future

Murthy M, Cheng YY, Holton JL, Bettencourt C.

Neuropathol Appl Neurobiol. 2021 Dec;47(7):897-909. doi: 10.1111/nan.12757. Epub 2021 Aug 5.

Emerging therapeutics in Huntington's disease

Wiggins R, Feigin A.

Expert Opin Emerg Drugs. 2021 Sep;26(3):295-302. doi: 10.1080/14728214.2021.1962285. Epub 2021 Aug 6.

An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches

Talebi M, Talebi M, Farkhondeh T, Kopustinskiene DM, Simal-Gandara J, Bernatoniene J, Samarghandian S.

Biomed Pharmacother. 2021 Sep;141:111906. doi: 10.1016/j.biopha.2021.111906. Epub 2021 Jul 16.

Mitophagy in Huntington's disease

Šonský I, Vodička P, Vodičková Kepková K, Hansíková H.

Neurochem Int. 2021 Oct;149:105147. doi: 10.1016/j.neuint.2021.105147. Epub 2021 Jul 28.

Hereditary Chorea Associated With and Aggravated by Systemic Lupus Erythematosus

Hussain T, Wali A, Hafizyar F, Eimal Latif AH, Joyce J, Walizada K, Malik S, Mushtaq Z.

Cureus. 2021 Jun 28;13(6):e15992. doi: 10.7759/cureus.15992. eCollection 2021 Jun.

Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies

Rizzo SA, Bartley O, Rosser AE, Newland B.

Prog Neurobiol. 2021 Oct;205:102126. doi: 10.1016/j.pneurobio.2021.102126. Epub 2021 Jul 30.

The neuroprotective potential of carotenoids in vitro and in vivo

Manochkumar J, Doss CGP, El-Seedi HR, Efferth T, Ramamoorthy S.

Phytomedicine. 2021 Oct;91:153676. doi: 10.1016/j.phymed.2021.153676. Epub 2021 Jul 21.

Systems modeling of metabolic dysregulation in neurodegenerative diseases

Baloni P, Funk CC, Readhead B, Price ND.

Curr Opin Pharmacol. 2021 Oct;60:59-65. doi: 10.1016/j.coph.2021.06.012. Epub 2021 Aug 2.

Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity

Heinz A, Nabariya DK, Krauss S.

Toxins (Basel). 2021 Jul 14;13(7):487. doi: 10.3390/toxins13070487.

Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases

Trudler D, Ghatak S, Lipton SA.

Int J Mol Sci. 2021 Jul 30;22(15):8196. doi: 10.3390/ijms22158196.

The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches

Schiavone S, Morgese MG, Tucci P, Trabace L.

Molecules. 2021 Aug 3;26(15):4700. doi: 10.3390/molecules26154700.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias